Frontiers in Clinical Drug Research -CNS and Neurological Disorders

View Sample Download Sample

Frontiers in Clinical Drug Research -CNS and Neurological Disorders

Volume 5

eBook: US $39 Special Offer (PDF + Printed Copy): US $151
Printed Copy: US $131
Library License: US $156
ISSN: 2451-8883 (Print)
ISSN: 2214-7527 (Online)
ISBN: 978-1-68108-586-9 (Print)
ISBN: 978-1-68108-585-2 (Online)
Year of Publication: 2017
DOI: 10.2174/97816810858521170501

Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurological and CNS disorders. Reviews presented in the series are mainly focused on clinical and therapeutic aspects of novel drugs intended for these targets.

Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field of neurology.

The fifth volume of this series features reviews that cover the following topics:

-drug treatment for spinal cord injury

-action tremors

-natural products for Alzheimer’s disease treatment

-non pharmacological approaches towards pain management

-biosensors for detecting neurodegenerative diseases

-NMDA receptor targeting

-alkaloid antidepressants

Indexed in: Scopus, EMBASE, EBSCO.

eBook: US $39 Special Offer: US $151 Printed Copy: US $131 Library License: US $156

Frontiers in Clinical Drug Research - CNS and Neurological Disorders presents the recent developments for the treatment of central nervous system (CNS) and nerve disorders. The book is a valuable resource for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for devising research plans in the field of neurology. The chapters are written by eminent authorities in the field. The contents of this volume represent exciting recent researches on spinal cord injury, essential tremor, alzheimer’s disease, pain management, neurotransmitters and neurodegenerative diseases, NMDA receptors, and plant alkaloids as antidepressants.

I hope that the readers will find these reviews valuable and thought provoking so that they may trigger further research in the quest for the new and novel therapies against CNS disorders.

I am grateful for the efforts made by the editorial personnel, especially Mr. Mahmood Alam (Director Publications), and Mr. Shehzad Naqvi (Senior Manager Publications) at Bentham Science Publishers.

Atta-ur-Rahman, FRS
Honorary Life Fellow
Kings College
University of Cambridge
UK